Akari Therapeutics, Plc
AKTX
$0.33
-$0.01-1.82%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.40M | -1.90M | -3.71M | -3.77M | -2.90M |
| Total Depreciation and Amortization | -- | -- | -- | 1.00K | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.85M | -945.00K | 988.00K | 104.00K | 59.00K |
| Change in Net Operating Assets | -575.00K | -416.00K | 567.00K | 1.54M | 1.35M |
| Cash from Operations | -2.12M | -3.26M | -2.15M | -2.12M | -1.49M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 382.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 382.00K | -- |
| Total Debt Issued | 2.10M | -- | -- | -3.00K | 0.00 |
| Total Debt Repaid | -202.00K | -214.00K | -514.00K | -973.00K | -336.00K |
| Issuance of Common Stock | 0.00 | 3.27M | 2.65M | 3.13M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -107.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 330.00K | -- | -- | -- |
| Cash from Financing | 1.90M | 3.38M | 2.13M | 2.15M | -443.00K |
| Foreign Exchange rate Adjustments | -3.00K | 4.00K | -- | 1.00K | 2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -227.00K | 129.00K | -17.00K | 413.00K | -1.93M |